Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1979-06-18
1981-02-10
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544360, 544368, 544370, A61K 31495, C07D40306, C07D41306, C07D41706
Patent
active
042501768
ABSTRACT:
Novel 1-substituted 4-(diarylmethyl)piperazine derivatives having antianaphylactic and antihistaminic properties, in which the 1-substituent is optionally substituted 2(3H) benzimidazol-2-one, 2(3H) benzothiazol-2-one, or 2(3H) benzoxazol-2-one.
REFERENCES:
patent: 2882271 (1959-04-01), Janssen
patent: 3362956 (1968-01-01), Archer
patent: 3369022 (1968-02-01), Sam et al.
patent: 3472854 (1969-10-01), Archer
patent: 3956328 (1976-05-01), Irikura
Kennis Ludo E. J.
Van der Aa Marcel J. M. C.
Van Heertum Albert H. M. T.
Vandenberk Jan
Coughlan, Jr. Paul M.
Dellenbaugh Geoffrey G.
Janssen Pharmaceutica N.V.
LandOfFree
Piperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1665501